A Purdue University research team is working to develop new smart soft contact lenses that continuously monitor and treat ...

Initiation of IOP reduction therapy fails to improve Visual field status in glaucoma patients suggests a study published in ...

A recent phase 3 clinical trial published in the Ophthalmology journal found 2 models of the travoprost intraocular implant ...

Prem Subramanian, MD, PhD, a professor of ophthalmology at the Sue Anschutz-Rodgers Eye Center, will use high-tech ocular ...

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma ...

Common glaucoma treatments may worsen ocular surface disease and meibomian gland dysfunction, leading to discomfort, redness, ...

The plaintiff alleged that her condition worsened under the doctor's care and that the doctor did the bare minimum to address ...

When astronauts land, they emerge from the capsule with numerous physiological changes that occurred while they were in the ...

Bayer to present new analyses from pivotal trials PULSAR & PHOTON featuring Eylea 8 mg at EURETINA: Berlin Thursday, September 12, 2024, 17:00 Hrs [IST] Bayer will present new ana ...

Press Release Nicox Announces Approval of ZERVIATE in ChinaNicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ...